D61.811

Clinical Causes: Use of specific medications such as chemotherapy drugs, antibiotics, anticonvulsants, and certain antipsychotics. Prolonged exposure to drugs that suppress bone marrow production. Drug interactions that increase the risk of bone marrow suppression. Genetic predisposition making some individuals more vulnerable to drug side effects. Existing health conditions that may increase susceptibility.

Key Symptoms: Fatigue and weakness due to anemia (low red blood cell count). Increased susceptibility to infections because of a reduced white blood cell count. Unusual bleeding or easy bruising resulting from low platelet counts. Paleness of the skin or mucous membranes. Fever and chills related to infections. Rapid heart rate or shortness of breath. Petechiae, which are small red or purple spots on the skin caused by bleeding beneath the surface.

Diagnosis Path: Diagnosis involves a thorough medical history, including recent medication use, and a series of blood tests such as a complete blood count (CBC). Additional tests may be conducted to rule out other causes of pancytopenia. Bone marrow biopsies may be performed to examine marrow activity and identify any suppression or abnormality. Healthcare providers assess medication history and clinical symptoms to determine if a drug is the likely cause.

Treatment Protocols: Managing drug-induced pancytopenia typically involves discontinuing the suspected medication under medical supervision. Supportive care includes blood transfusions for severe anemia or bleeding, antibiotics or antifungal medications to prevent or treat infections, and medications to stimulate blood cell production. Close monitoring of blood counts is essential, and treatment plans are tailored based on severity and underlying causes. In some cases, stopping the causative drug leads to gradual recovery of blood cell counts.